886 related articles for article (PubMed ID: 27769634)
1. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
[TBL] [Abstract][Full Text] [Related]
2. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
[TBL] [Abstract][Full Text] [Related]
3. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
4. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
Beek MA; Gobardhan PD; Klompenhouwer EG; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2015 Jan; 41(1):59-63. PubMed ID: 25468747
[TBL] [Abstract][Full Text] [Related]
5. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
[TBL] [Abstract][Full Text] [Related]
6. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
[TBL] [Abstract][Full Text] [Related]
7. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
Noguchi M; Inokuchi M; Noguchi M; Morioka E; Kurita T
Eur J Surg Oncol; 2020 Dec; 46(12):2218-2220. PubMed ID: 32912671
[TBL] [Abstract][Full Text] [Related]
8. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
9. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
10. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
11. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
[TBL] [Abstract][Full Text] [Related]
12. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
[TBL] [Abstract][Full Text] [Related]
13. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.
Parks RM; Cheung KL
Breast; 2017 Jun; 33():57-70. PubMed ID: 28282588
[TBL] [Abstract][Full Text] [Related]
14. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
Seyednejad N; Kuusk U; Wiseman SM
Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
[TBL] [Abstract][Full Text] [Related]
15. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
16. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.
Noguchi M; Noguchi M; Ohno Y; Morioka E; Nakano Y; Kosaka T; Kurose N; Minato H
Eur J Surg Oncol; 2016 May; 42(5):650-6. PubMed ID: 27005806
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
Wijaya WA; Peng J; He Y; Chen J; Cen Y
Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
[TBL] [Abstract][Full Text] [Related]
18. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
[TBL] [Abstract][Full Text] [Related]
19. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
Trials; 2013 Apr; 14():111. PubMed ID: 23782712
[TBL] [Abstract][Full Text] [Related]
20. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.
Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J
Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
